AMRX logo

AMRXAmneal Pharmaceuticals Inc - Ordinary Shares - Class A

$12.78
$0.125
(0.99%)
Today
Updated: 02:43 PM EDT
EarningsAug 4
Mkt Cap$4.04B
Vol612,763.00
News
all
press releases
Is Amneal Pharmaceuticals (AMRX) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks
News Placeholder
More News
News Placeholder
Is it a Good Idea to Invest in Amneal Pharmaceuticals Stock Now?
AMRX is building momentum with growth across specialty drugs and biosimilars, supported by new launches and a diversified portfolio.
Zacks
News Placeholder
Why Amneal Pharmaceuticals (AMRX) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks
News Placeholder
3 Reasons Why Growth Investors Shouldn't Overlook Amneal (AMRX)
Amneal (AMRX) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Zacks
News Placeholder
Should Value Investors Buy Amneal Pharmaceuticals (AMRX) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks
News Placeholder
Amneal (AMRX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Revised)
Although the revenue and EPS for Amneal (AMRX) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks
News Placeholder
Do Options Traders Know Something About Amneal Stock We Don't?
Investors need to pay close attention to AMRX stock based on the movements in the options market lately.
Zacks
News Placeholder
Artemis Investment Management LLP Buys Shares of 124,899 Amneal Pharmaceuticals, Inc. $AMRX
Artemis Investment Management LLP bought a new stake in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 124,899 shares of the company's stock, valued at approximately $1...
MarketBeat
News Placeholder
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Short Interest Update
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Get Free Report) was the target of a large increase in short interest in the month of April. As of April 15th, there was short interest totaling 8,556,479...
MarketBeat
News Placeholder
Is Amneal (AMRX) a Solid Growth Stock? 3 Reasons to Think "Yes"
Amneal (AMRX) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Zacks
<
1
2
...
>